This month, the European research collaboration European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS) published its research findings in The Lancet Neurology. JARA-BRAIN scientist Prof. Dr. Jörg B. Schulz, director of the Department of Neurology in University Hospital Aachen and spokesperson for the Aachen centre for rare diseases (ZSEA), heads the patient registry and a study on the natural course of the disease. Together with his senior physician Prof. Dr. Kathrin Reetz (JARA-BRAIN) and an expert team from University Hospital Aachen, he published the data from a prospective cross-sectional study.
Successful translation: the amino acid 18F-fluoroethyl tyrosine (FET), which was developed by JARA-BRAIN scientists, has been licensed for the first time as a radiopharmaceutical agent for the diagnosis of brain diseases in humans by the Swiss Agency for Therapeutic Products.
The JARA-BRAIN scientist Dr. Irene Neuner received the German Association for Psychiatry, Psychotherapy and Psychosomatics’s (DGPPN) 2014 research award for her outstanding research achievements in the area of innovative imaging. The award was presented for the first time to three scientists at the DGPPN Annual Congress in Berlin and is endowed with € 5,000 for each winner.
Mental illness is one of the most frequent illnesses of children and young people. This is also reflected in the number of patients treated at University Hospital Aachen's Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy. The number of patients here has increased by over 70 % in the past few years. This is why the hospital is extending its premises. In an interview, JARA-BRAIN scientist and head of department, Prof. Beate Herpertz-Dahlmann, outlines the new facilities available at the child and adolescent psychiatry department.
A gift voucher for the cinema, praise from your parents, or nothing at all: rewards are regarded as desirable to a different extent. In a study by University Hospital Aachen's Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, JARA-BRAIN scientists recently investigated which incentives had an effect on healthy test subjects, as well as on patients with attention deficit hyperactivity disorder (ADHD) and autism. The findings will help to tailor treatment as closely as possible to the needs of certain groups of patients.
